🧬 ICD-10 CM M72.2 — Plantar Fascial Fibromatosis
Billable Code Confirmed
ICD-10 CM M72.2 is a complete, 4-character ICD-10-CM code requiring no additional digits or laterality specification, making it fully billable as-is for both plantar fascial fibromatosis (Ledderhose disease) and the far more commonly reported included synonym, plantar fasciitis, in any care setting for FY2026.
Non-Billable Parent Codes
M72 (Fibroblastic disorders) is a non-billable category-level code requiring a fourth character to specify the fibroblastic disorder subtype (e.g., palmar, plantar, nodular) and cannot be submitted alone on any claim.
Clinical Context
The key clinical distinction driving use of M72.2 is confirmed plantar fascia pathology — either true fibromatous nodule formation (Ledderhose disease) or the far more common degenerative/microtear-based inflammatory condition, plantar fasciitis — as opposed to nonspecific heel or foot pain without a confirmed structural diagnosis.
Code Classification
ICD-10 CM M72.2 is a diagnosis code (ICD-10-CM), used to report the underlying medical condition supporting medical necessity for evaluation, imaging, conservative therapy, injections, or surgical intervention; it is never used as a procedure code.
🔍 Code Description
ICD-10 CM M72.2 is officially defined by the WHO and CMS/NCHS as “plantar fascial fibromatosis,” a fibroblastic soft tissue disorder characterized by nodular thickening along the plantar fascia due to hypercellular, spindle-shaped fibroblast proliferation, clinically known as Ledderhose disease. Despite this specific official descriptor, ICD-10-CM coding conventions explicitly designate plantar fasciitis — a much more common degenerative and inflammatory condition causing heel and arch pain — as an included synonym under this same code, meaning both conditions, though clinically and pathophysiologically distinct, share M72.2 as their single reportable diagnosis code. This dual-use design means coders must rely on the clinical documentation itself to determine which condition is present, since the code descriptor alone does not distinguish between true fibromatous nodules and inflammatory fasciitis.
Unlike many musculoskeletal codes in the M70-M79 soft tissue disorder block, M72.2 carries no laterality character, meaning right, left, and bilateral presentations are all reported using the identical code; laterality must instead be documented in the clinical note and, when relevant to a procedure, captured through the CPT-level modifier (-RT, -LT) rather than a diagnosis code modifier. When a calcaneal spur is confirmed on imaging alongside plantar fasciitis, the appropriate calcaneal spur code (M77.31 right, M77.32 left) should be reported as an additional, separately coded diagnosis alongside M72.2, since ICD-10-CM does not consider these two findings mutually inclusive under a single code.
🌳 Code Tree / Hierarchy
M72 Fibroblastic disorders ❌ Non-billable
│
├── M72.0 Palmar fascial fibromatosis [Dupuytren] ✅ Billable
├── M72.1 Knuckle pads ✅ Billable
│
├── M72.2 [THIS SUBCATEGORY IS ALSO THE FULL CODE]
│ │
│ └── M72.2 Plantar fascial fibromatosis ◀ THIS CODE ✅ Billable
│
├── M72.4 Pseudosarcomatous fibromatosis ✅ Billable
└── M72.6 Necrotizing fasciitis ✅ BillableSpecificity Matters Even Without Subcodes
Although M72.2 requires no additional laterality or severity characters, payers still expect the clinical note to document laterality (right, left, bilateral) and chronicity (acute versus chronic) in the narrative, since this information supports medical necessity determinations for procedures like corticosteroid injection (20551) or extracorporeal shock wave therapy even though it does not change the diagnosis code itself.
Tip
Do not confuse M72.2 with nonspecific heel pain codes such as M79.671 (right foot pain) or M79.672 (left foot pain) — those symptom-only codes should only be used when no confirmed structural diagnosis has been established; once plantar fasciitis or plantar fascial fibromatosis is clinically confirmed, M72.2 replaces the symptom code as the primary diagnosis.
✅ Includes
- Plantar fasciitis — The most common clinical presentation reported under this code, representing degenerative microtearing and inflammatory changes of the plantar fascia causing heel and arch pain, distinct from but coded identically to true fibromatosis.
- Plantar fibromatosis (Ledderhose disease) — The official, more specific pathological entity this code was originally designed to capture, involving benign fibrous nodule formation along the plantar fascia.
❌ Excludes
Excludes 1
Danger
The most common Excludes 1 error involving M72.2 is inadvertently using the general fibromatosis code M72.4 (pseudosarcomatous fibromatosis) for a plantar-specific presentation instead of the correct site-specific M72.2; coders must always confirm the anatomical site documented (plantar fascia specifically) before defaulting to a broader fibromatosis code.
Excludes 2
- ICD-10 CM M77.31 (Calcaneal spur, right foot) and M77.32 (Calcaneal spur, left foot) — These may be coded together with M72.2 when imaging confirms a distinct calcaneal spur finding in addition to the plantar fascia pathology, since the two conditions are anatomically related but represent separately identifiable structural findings that both warrant individual capture.
📋 Clinical Overview
Ledderhose Disease vs. Plantar Fasciitis — Shared Code, Distinct Pathology
Although both conditions are captured under the single code M72.2, they represent fundamentally different disease processes with different treatment pathways, and clinical documentation should clearly specify which condition is being addressed to support downstream treatment authorization decisions.
| Feature | M72.2 (Plantar Fasciitis) | M72.2 (Ledderhose Disease) | Related M77.31 (Calcaneal Spur) |
|---|---|---|---|
| Pathophysiology | Degenerative microtearing and chronic inflammatory changes at the plantar fascia origin, typically at the calcaneal insertion. | True fibroblastic proliferation forming discrete, palpable nodules along the plantar fascia, unrelated to inflammation. | Bony calcification/spur formation at the calcaneal tuberosity, often coexisting with but distinct from fascial pathology. |
| Typical Presentation | Sharp heel pain, worst with first steps in the morning (“post-static dyskinesia”), improving with activity. | Palpable, often painless or mildly tender nodules in the arch, sometimes bilateral, associated with Dupuytren contracture in some patients. | Often asymptomatic incidental imaging finding, though may contribute to heel pain when large. |
| Primary Treatment | Conservative therapy (stretching, orthotics, NSAIDs), corticosteroid injection (20550), or ESWT. | Observation for small nodules; surgical excision (fasciectomy) considered for large, painful, or rapidly growing nodules. | Typically managed conservatively; rarely requires isolated surgical removal. |
Important
A key CDI trigger for this code is ensuring the provider’s documentation specifies which condition — plantar fasciitis (inflammatory/degenerative) versus true fibromatous nodules (Ledderhose disease) — is being treated, since this distinction, while not changing the ICD-10-CM code itself, materially affects clinical management decisions and should be reflected in the visit note to support the medical necessity of the chosen treatment pathway.
Manifestations & Symptom Burden
- Heel pain with first-step morning exacerbation — The classic presenting symptom of plantar fasciitis, often described as sharp or stabbing pain at the plantar heel that improves somewhat with continued ambulation.
- Palpable plantar nodules — Characteristic of Ledderhose disease/true fibromatosis, presenting as one or more firm, subcutaneous masses along the medial plantar arch.
- Arch pain with prolonged standing or activity — Common in both presentations, reflecting mechanical strain on the inflamed or nodular fascia during weight-bearing activity.
- Bilateral involvement — More characteristic of Ledderhose disease, which has a recognized association with Dupuytren contracture and Peyronie disease as part of a fibromatosis syndrome spectrum.
Tip
💰 HCC Risk Adjustment
| Component | Value |
|---|---|
| HCC Category | N/A — Not HCC-Mapped (CMS-HCC Model V28, PY2026) |
| RAF Contribution | None |
| RxHCC Mapping | None |
| Annual Recapture Required | No |
ICD-10 CM M72.2 does not contribute to risk adjustment factor scoring under the current CMS-HCC or RxHCC models for payment year 2026, since plantar fascial fibromatosis is classified as a lower-acuity, localized musculoskeletal soft tissue condition rather than a chronic systemic disease category recognized in the HCC hierarchy. Medicare Advantage plans and ACO REACH risk-bearing entities should not prioritize this diagnosis for annual capture campaigns, as it carries no payment impact under risk-based reimbursement models. The diagnosis remains clinically and billing-relevant primarily for supporting medical necessity of associated E/M visits, injections, imaging, and procedural interventions rather than for population risk stratification purposes.
🏥 MS-DRG Assignment
| Component | Value |
|---|---|
| MDC | N/A — Not a primary MDC driver |
| DRG with MCC | N/A — Not typically an inpatient primary diagnosis |
| DRG with CC | N/A — Not typically an inpatient primary diagnosis |
| DRG without CC/MCC | N/A — Not typically an inpatient primary diagnosis |
ICD-10 CM M72.2 is almost exclusively managed in the outpatient, office, or ambulatory surgery center setting and does not function as a principal diagnosis driving inpatient MS-DRG assignment under FY2026 IPPS methodology; on the rare inpatient claim where it appears, it would be reported as a secondary or incidental diagnosis rather than the admission driver. There is no standalone national NCD specifically governing this diagnosis; however, several Medicare Administrative Contractors maintain jurisdiction-specific Local Coverage Determinations and Billing and Coding Articles for tendon/ligament injections (20550) and extracorporeal shock wave therapy that explicitly list M72.2 as a covered, medically necessary supporting diagnosis code — coders should verify the applicable LCD (e.g., Palmetto GBA, Noridian, CGS) through the CMS Medicare Coverage Database before submitting claims for associated procedures, since coverage criteria (such as required duration of conservative therapy before injection or ESWT) vary by jurisdiction.
🔗 Related ICD-10-CM Codes
Fibroblastic Disorder Group
- M72.0 — Palmar fascial fibromatosis (Dupuytren contracture), the hand-equivalent fibroblastic disorder sharing pathophysiology with Ledderhose disease.
- M72.1 — Knuckle pads, another benign fibroblastic proliferation within the same M72 category.
- M72.4 — Pseudosarcomatous fibromatosis, a distinct fibroblastic disorder subtype excluded from M72.2.
- M72.6 — necrotizing fasciitis, a serious, unrelated infectious soft tissue emergency within the same M72 category but requiring urgent, distinct management.
Related Foot/Heel Pathology Group
- M77.31 — Calcaneal spur, right foot; commonly coexists with plantar fasciitis and may be separately coded.
- M77.32 — Calcaneal spur, left foot; left-sided equivalent, separately coded when confirmed.
- M79.671 — Pain in right foot; symptom-only code used prior to confirmed structural diagnosis.
- M79.672 — Pain in left foot; symptom-only code used prior to confirmed structural diagnosis.
🛠️ Commonly Associated CPT Codes
- 20550 — Injection(s); single tendon sheath, or ligament, aponeurosis: the most frequently paired CPT code with M72.2, used for corticosteroid or other therapeutic injection directly into the plantar fascia; several MAC LCDs explicitly list M72.2 as a covered supporting diagnosis for this injection code.
- 28008 — Fasciotomy, foot and/or toe: reported when surgical release of the plantar fascia is performed for chronic, treatment-resistant plantar fasciitis; requires documentation of failed conservative therapy per most payer medical necessity policies.
- 28060 — Fasciectomy, plantar fascia; partial: used specifically for surgical excision of a fibromatous nodule in confirmed Ledderhose disease, distinguishing it clinically from the fasciotomy approach used for inflammatory plantar fasciitis.
- 97110 — Therapeutic exercise: commonly billed by physical therapy providers for stretching and strengthening protocols targeting plantar fasciitis management, paired with M72.2 as the supporting diagnosis.
- 73630 — Radiologic examination, foot; complete, minimum of 3 views: used to evaluate for coexisting calcaneal spur or rule out other structural pathology when plantar fasciitis or fibromatosis is clinically suspected.
NCCI Bundling Considerations
CPT 20550 (plantar fascia injection) and 97110 (therapeutic exercise) performed on the same date of service by the same provider may be subject to NCCI edits requiring modifier -59 to indicate distinct, separately identifiable services if both are medically necessary and clearly documented as such.
🔬 ICD-10-PCS Crosswalk
| PCS Code | Full Description | Modality |
|---|---|---|
| 0JBQ0ZZ | Excision of Right Foot Subcutaneous Tissue and Fascia, Open Approach | Represents surgical excision of a fibromatous nodule (Ledderhose disease) or plantar fascia tissue via open approach on the right foot when performed in the inpatient setting. |
| 0JBR0ZZ | Excision of Left Foot Subcutaneous Tissue and Fascia, Open Approach | Left-sided equivalent of 0JBQ0ZZ, used for inpatient excisional procedures targeting the left plantar fascia. |
| 0J8Q0ZZ | Division of Right Foot Subcutaneous Tissue and Fascia, Open Approach | Represents surgical release/fasciotomy of the right plantar fascia when performed as an inpatient procedure for severe, treatment-resistant plantar fasciitis. |
| 0J8R0ZZ | Division of Left Foot Subcutaneous Tissue and Fascia, Open Approach | Left-sided equivalent of 0JBQ0ZZ, used for left-sided inpatient plantar fasciotomy procedures. |
💊 Coding Scenarios and Examples
Scenario 1
A 45-year-old female presents with 4 months of sharp right heel pain, worst with her first steps each morning, consistent with clinical plantar fasciitis. Conservative treatment with stretching and orthotics has failed, and the podiatrist performs an ultrasound-guided corticosteroid injection into the plantar fascia.
Correct Coding: M72.2, 20550--RT
Sequencing: M72.2 is listed as the primary diagnosis supporting medical necessity for the injection procedure; modifier -RT on 20550 specifies the right-sided procedure site since the diagnosis code itself carries no laterality character.
CDI Note
Documentation should confirm at least the minimum duration of failed conservative therapy required by the applicable MAC’s LCD for injection coverage before the claim is submitted.
Scenario 2
A 58-year-old male with longstanding bilateral firm, non-tender nodules along both plantar arches, worsening over 2 years, is diagnosed with Ledderhose disease (plantar fibromatosis) after clinical exam and ultrasound confirm fibromatous nodules rather than inflammatory fasciitis. He also has a documented history of Dupuytren contracture of the right hand.
Correct Coding: M72.2 (bilateral, documented in narrative), M72.0 (right hand Dupuytren contracture, historical)
Sequencing: M72.2 is sequenced first as the primary reason for the current encounter; M72.0 is listed as a secondary diagnosis reflecting the patient’s related fibromatosis history, supporting the clinical association between these fibroblastic disorders.
CDI Note
Because M72.2 has no laterality character, the clinical note must explicitly state “bilateral” involvement in the narrative to satisfy documentation completeness standards, even though the code itself remains unchanged.
Scenario 3
A 62-year-old female with a 3-year history of a painful, enlarging plantar fibroma of the left foot, confirmed on MRI, undergoes surgical partial fasciectomy after failing conservative management including custom orthotics and corticosteroid injections.
Correct Coding: M72.2, 28060--LT
Sequencing: M72.2 is the primary diagnosis supporting medical necessity for the surgical fasciectomy; modifier -LT specifies the left-sided procedure since M72.2 itself does not carry laterality.
CDI Note
The operative note and pathology report should clearly document confirmed fibromatous nodule excision (supporting the Ledderhose disease/true fibromatosis clinical picture) rather than a simple fasciotomy, since this distinguishes the surgical approach and CPT code selection (28060 fasciectomy versus 28008 fasciotomy).
⚠️ Coding Pitfalls and Tips
- Pitfall 1: Using nonspecific heel/foot pain codes (M79.671, M79.672) instead of M72.2 once a provider has clinically confirmed plantar fasciitis or fibromatosis — the symptom code should only be used prior to or in the absence of a confirmed structural diagnosis.
- Pitfall 2: Failing to document laterality in the clinical narrative for M72.2, since this code carries no laterality character and payers may still request this detail to support the medical necessity of a laterality-specific procedure code and modifier.
- Pitfall 3: Omitting the additional calcaneal spur code (M77.31 or M77.32) when imaging clearly confirms a coexisting heel spur alongside plantar fasciitis, since these are separately codable findings under Excludes 2 conventions.
- Pitfall 4: Assuming a dedicated national NCD exists for plantar fasciitis treatment — coders must verify jurisdiction-specific LCDs for procedures like 20550 injections or ESWT, since coverage criteria (including required conservative therapy duration) vary significantly by Medicare Administrative Contractor.
- Pitfall 5: Confusing the fasciotomy code (28008) with the fasciectomy code (28060) — fasciotomy describes a release/division procedure typically for inflammatory plantar fasciitis, while fasciectomy describes excision of a fibromatous nodule and should only be selected when true Ledderhose disease pathology is confirmed.
- Pitfall 6: Incorrectly attempting to append a fourth or fifth character to M72.2 in search of additional specificity — this code is already complete and fully billable at 4 characters with no further subdivision available in the FY2026 ICD-10-CM code set.